clofibric acid has been researched along with Thromboembolism, Venous in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lacut, K | 1 |
| Le Gal, G | 1 |
| Abalain, JH | 1 |
| Mottier, D | 1 |
| Oger, E | 1 |
1 other study available for clofibric acid and Thromboembolism, Venous
| Article | Year |
|---|---|
Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?
Topics: Aged; Aged, 80 and over; Case-Control Studies; Clofibric Acid; Databases, Factual; Female; Homocyste | 2008 |